Biomarkers Coronavirus Immunotherapies Cancer Researchers Have a Head Start in Fight Against COVID-19 By Staff Reports 3 weeks ago Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or
cancer Immunotherapies Pharmaceuticals Targeted Drugs and Immunotherapies May Lower Risk of Therapy-Related Hematologic Cancers By Staff Reports 1 month ago While breakthrough treatments have emerged for several cancers over the last two decades, driving striking
Biotechnology cancer Immunotherapies Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation By Staff Reports 3 months ago Although metastatic castration-resistant prostate cancer (mCRPC) typically has limited response to immunotherapy, a subset of
Biotechnology cancer Coronavirus Immunotherapies COVID-19 recommendations for patients receiving anti-cancer immunotherapies By Staff Reports 3 months ago We should all be doing our best to keep from catching COVID-19, if not for
Biotechnology Breast Cancer Immunotherapies New discovery betters development of immunotherapies for breast cancer treatment By Staff Reports 4 months ago New cancer immunotherapy approaches are revolutionizing treatment options for breast cancer patients. However, many lead
Biotechnology cancer Clinical Trials Immunotherapies Human Immune Monitoring Center at Mount Sinai to analyze the effectiveness of a novel cancer therapy drug By Staff Reports 8 months ago The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai
Biotechnology cancer drug development Immunotherapies Scientists develop promising drug for treating ovarian and pancreatic cancers By Staff Reports 12 months ago Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called
Biotechnology cancer Immunotherapies Researchers from Johns Hopkins Kimmel Cancer Center Successfully Pilot Multidisciplinary Approach for Addressing Immunotherapy-Related Toxicities By Staff Reports 1 year ago New research from the Johns Hopkins Kimmel Cancer Center, published in the June 2019 issue
Biotechnology cancer drug development Immunotherapies UCLA researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer By Staff Reports 1 year ago A UCLA-led research team has pinpointed a three-drug combination that could prove to be an
Biotechnology cancer Clinical Trials Immunotherapies Kidney disease UT Southwestern develops test to predict immunotherapy response in kidney cancer By Staff Reports 1 year ago A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit
cancer Immunotherapies Immunotherapy drug improves five-year survival rate of people with advanced lung cancer By Staff Reports 1 year ago In a study led by UCLA investigators, treatment with the immunotherapy drug pembrolizumab helped more
Immunotherapies Tumor Mutations May Predict Response to Immunotherapy By Staff Reports 1 year ago Checkpoint inhibitor drugs that stimulate the immune system have become a growing success story in
cancer Cancer Discovery Researchers find new target to improve response to cancer immunotherapy By Staff Reports 1 year ago New findings suggest an unexpected path to killing cancer cells could make the hottest cancer
cancer Cancer Exports Molecular ‘Saboteurs’ to Remotely Disarm Immune System By Staff Reports 1 year ago Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that
cancer Immunotherapies Cancer Exports Molecular ‘Saboteurs’ to Remotely Disarm Immune System By Staff Reports 1 year ago Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that
Immunotherapies Cancer Exports Molecular ‘Saboteurs’ to Remotely Disarm Immune System By Staff Reports 1 year ago Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that
Biotech Company News Merck to Acquire Immune Design By Staff Reports 1 year ago Merck and Immune Design announced that the companies have entered into a definitive agreement under
Immunotherapies Immunotherapy can be effective in treating people with recurrent glioblastoma By Staff Reports 1 year ago A UCLA-led study suggests that for people with recurrent glioblastoma, administering an immunotherapy drug before
Biotech Company News Bristol-Myers Squibb to Acquire Celgene By Staff Reports 1 year ago Bristol-Myers bulks up cancer portfolio with $74 billion Celgene deal (Reuters) – Bristol-Myers Squibb Co
cancer Cancer Discovery Cancer screening Immunotherapies Immunotherapy combination and chemotherapy show encouraging results in Phase II acute myeloid leukemia study By Staff Reports 2 years ago A triple therapy combining two immune checkpoint inhibitors (ICPIs) with the standard-of-care chemotherapy, a hypomethylating